Home > Healthcare & Medical Devices > Blood Platelets Market

Blood Platelets Market Size By Platelet (Whole Blood Derived Platelets, Apheresis Derived Platelets), By Application (Hemophilia, Thrombocytopenia, Perioperative Indications, Platelet Function Disorders, Hemato-oncology), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2030

  • Report ID: GMI2849
  • Published Date: Oct 2022
  • Report Format: PDF

Industry Overview

Blood Platelets Market size was valued at USD 4.5 billion in 2021. Driven by the growing instances of blood-related and chronic disorders such as hemophilia, leukocytosis, and thrombocytopenia, the industry is anticipated to grow at 4% CAGR from 2022 to 2030.
 

Blood Platelets Market Research Report

Get more details on this report - Request Free Sample PDF
 

Increasing mortality rates and prolonged hospitalization due to the growing prevalence of blood-related disorders have increased the need for blood platelets in healthcare. The demand has steadily increased in recent years. Meanwhile, a consistent rise in the global geriatric population has also augmented the industry outlook as the demographic is more susceptible to blood disorders.
 

High risk of transfusion-transmitted infections may hinder the industry expansion

The risk of infection during blood transfusions may act as a hindrance to the blood platelets market value. Patient safety is among the top priorities of healthcare institutions. However, instances of bacterial contamination of blood products like platelets is still a common infection risk during transfusions. Bacterial contamination occurs in nearly one in every 2,000-2,500 platelet transfusions, and transfusion-transmitted sepsis can also result in severe prolonged illness and even mortality.
 

Higher preference among end-users to augment apheresis-derived platelets segment progression

Global Blood Platelets Market Share, By Platelet

Get more details on this report - Request Free Sample PDF
 

Based on platelet, apheresis-derived platelets segment is expected to register 4% CAGR between 2022 and 2030, reaching a valuation of USD 4 billion during the forecast duration. The segment growth is likely to be fueled by a growing preference for apheresis-derived platelets among healthcare facilities, including hospitals, and ambulatory surgical centers, to effectively meet the platelet requirements of patients suffering from blood and chronic diseases.
 

Increasing awareness around better disease management to foster industry landscape

Based on application, the blood platelets market from thrombocytopenia segment held 44% revenue share in 2021 and is set to exceed USD 3.2 billion by 2030 impelled by increasing awareness about the extensive benefits of blood platelets in precisely managing thrombocytopenia. Additionally, rising cases of thrombocytopenia and the availability of higher quality blood and platelet transfusions are also expected to outline the segment outlook.
 

Growing inclination for outpatient surgical procedures to help ambulatory surgical centers segment gain traction

Global Blood Platelets Market, By End-use

Get more details on this report - Request Free Sample PDF
 

Based on the end-use spectrum, ambulatory surgical centers accounted for 10% business share in 2021, with estimates expecting it to register 4% CAGR through 2030. Increasing number of ambulatory surgical centers and growing patient preference towards outpatient surgical procedures are boosting the industry size. Their affordability, convenience, and high-quality treatment are further contributing to segment development.
 

Rising cases of chronic and blood-related disorders to make Europe a prominent revenue pocket

  Global Blood Platelets Market, By Region

Get more details on this report - Request Free Sample PDF
 

Europe blood platelets market is anticipated to register over USD 1 billion by 2030, driven primarily by the rising prevalence of chronic conditions comprising cardiac and orthopedic diseases.  According to the European Society of Cardiology, each year more than 6 million new cases of cardiovascular disease are reported within the EU, and over 11 million are reported within Europe as a whole.
 

Capacity expansion initiatives to define the competitive ecosystem

Some of the key market players partaking in the blood platelets market are America’s Blood Centers, American National Red Cross, Association for the Advancement of Blood & Biotherapies, Blood Centers of America, Brazilian Red Cross, Canadian Blood Services, European Blood Alliance (EBA), French Red Cross, German Red Cross, Indian Red Cross Society, Italian Red Cross, Japanese Red Cross Society, Red Cross Society of China, Spanish Red Cross, and others. Many of these players are emphasizing on capacity expansion initiatives to enhance global reach.
 

COVID-19 impact on the blood platelets market trends

The COVID-19 pandemic has had a severe impact on the industry outlook as fear of infection led to the cancellation or indefinite postponement of community donor events and disrupted blood collection initiatives. Also, reduced donations from the elderly population, who are major contributors in blood donation but were highly susceptible to virus transmission, hampered the industry growth. On the other hand, the pandemic also benefitted the industry landscape as it compelled blood donation units to incorporate improved standard operating procedures (SOPs) for better management of blood collection practices.
 

The blood platelets market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2030 for the following segments:

By Platelet

  • Whole Blood Derived Platelets
  • Apheresis Derived Platelets

By Application

  • Hemophilia
  • Thrombocytopenia
  • Perioperative Indications
  • Platelet Function Disorders
  • Hemato-oncology
  • Others

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea 
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global market for blood platelets registered a valuation of USD 4.5 billion and is expected to record over 4% CAGR during 2022-2030.

Some of the major contenders operating in the market are America’s Blood Centers, American National Red Cross, Brazilian Red Cross, Canadian Blood Services, European Blood Alliance (EBA), French Red Cross, German Red Cross, Indian Red Cross Society, Italian Red Cross, and Japanese Red Cross Society, among others.

Europe blood platelets market is slated to be worth over USD 1 billion by 2030 on account of the growing cases of orthopedic and cardiovascular diseases in the region and the subsequent need for lifesaving treatment procedures.

The apheresis-derived platelets segment is anticipated to grow at over 4% CAGR through 2030, driven by a higher demand from hospitals and ambulatory surgical centers to effectively meet the platelet requirements of patients suffering from blood and chronic diseases.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 16
  • Tables & Figures: 244
  • Countries covered: 18
  • Pages: 179

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount